Researchers test gentler start to opioid addiction treatment
NCT ID NCT07439549
Summary
This study is testing a new method to help people with opioid addiction start taking buprenorphine, a medication that reduces cravings and withdrawal. The method uses small, timed doses of another drug (naloxone) to gently trigger mild withdrawal symptoms before giving the treatment medication, aiming to make the process safer and more comfortable. Researchers want to see if this approach works well in both hospital and clinic settings for 12 participants over 28 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hope to Health Research & Innovation Centre
Vancouver, British Columbia, V6A 1H2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Vancouver General Hospital
Vancouver, British Columbia, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.